Literature DB >> 26668085

Sarcopenia Adversely Impacts Postoperative Clinical Outcomes Following Gastrectomy in Patients with Gastric Cancer: A Prospective Study.

Su-Lin Wang1, Cheng-Le Zhuang1, Dong-Dong Huang1, Wen-Yang Pang1, Neng Lou1, Fan-Feng Chen1, Chong-Jun Zhou1, Xian Shen2, Zhen Yu3,4.   

Abstract

BACKGROUND: Sarcopenia is characterized by decreased skeletal muscle plus low muscle strength and/or physical performance. This study was performed to determine the association of sarcopenia with short-term postoperative outcomes after gastrectomy for gastric cancer.
METHODS: We conducted a prospective study of 255 consecutive patients with gastric cancer who underwent curative gastrectomy. The sarcopenia elements, including lumbar skeletal muscle index, handgrip strength, and gait speed, were measured before surgery. Patients were followed up after gastrectomy to gain the actual clinical outcomes. Factors contributing to postoperative complications were analyzed by univariate and multivariate analysis.
RESULTS: Sarcopenia was present in 32 of 255 patients (12.5 %), and was significantly correlated with advance age, lower body mass index, higher nutritional risk screening (NRS) 2002 score, and lower preoperative serum albumin and hemoglobin. Compared with non-sarcopenic patients, sarcopenic patients had a higher risk of postoperative complications, longer postoperative hospital stay, and more hospital costs. In univariate analysis, sarcopenia (p < 0.001), nutritional risk (NRS 2002 score ≥3; p = 0.003), advanced age (≥75 years; p = 0.014), anemia (p = 0.012), hypoalbuminemia (p = 0.029), and diabetes (p = 0.014) were associated with postoperative complications. Multivariable analysis revealed that sarcopenia (p < 0.001) and diabetes (p = 0.006) were independent predictors of postoperative complications.
CONCLUSIONS: Sarcopenia is an independent predictor of postoperative complications in patients with gastric cancer after gastrectomy.

Entities:  

Mesh:

Year:  2015        PMID: 26668085     DOI: 10.1245/s10434-015-4887-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  62 in total

1.  Pre-operative Sarcopenia Identifies Patients at Risk for Poor Survival After Resection of Biliary Tract Cancers.

Authors:  Jeffery Chakedis; Gaya Spolverato; Eliza W Beal; Ingrid Woelfel; Fabio Bagante; Katiuscha Merath; Steven H Sun; Aaron Chafitz; Jason Galo; Mary Dillhoff; Jordan Cloyd; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2018-05-31       Impact factor: 3.452

2.  Physical decline and its implications in the management of oesophageal and gastric cancer: a systematic review.

Authors:  Linda O'Neill; Jonathan Moran; Emer M Guinan; John V Reynolds; Juliette Hussey
Journal:  J Cancer Surviv       Date:  2018-05-23       Impact factor: 4.442

3.  Sarcopenia related to neoadjuvant chemotherapy and perioperative outcomes in resected gastric cancer: a multi-institutional analysis.

Authors:  Katelin A Mirkin; Franklyn E Luke; Alexandra Gangi; Jose M Pimiento; Daniel Jeong; Christopher S Hollenbeak; Joyce Wong
Journal:  J Gastrointest Oncol       Date:  2017-06

Review 4.  The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature.

Authors:  Hánah N Rier; Agnes Jager; Stefan Sleijfer; Andrea B Maier; Mark-David Levin
Journal:  Oncologist       Date:  2016-07-13

5.  Role of frailty and nutritional status in predicting complications following total gastrectomy with D2 lymphadenectomy in patients with gastric cancer: a prospective study.

Authors:  Fan-Feng Chen; Fei-Yu Zhang; Xuan-You Zhou; Xian Shen; Zhen Yu; Cheng-Le Zhuang
Journal:  Langenbecks Arch Surg       Date:  2016-08-02       Impact factor: 3.445

6.  Computed tomography-quantified body composition predicts short-term outcomes after gastrectomy in gastric cancer.

Authors:  Y Zhang; J P Wang; X L Wang; H Tian; T T Gao; L M Tang; F Tian; J W Wang; H J Zheng; L Zhang; X J Gao; G L Li; X Y Wang
Journal:  Curr Oncol       Date:  2018-10-31       Impact factor: 3.677

Review 7.  Sarcopenia in gastric cancer: when the loss costs too much.

Authors:  Elena Ongaro; Vanessa Buoro; Marika Cinausero; Riccardo Caccialanza; Annalisa Turri; Valentina Fanotto; Debora Basile; Maria Grazia Vitale; Paola Ermacora; Giovanni Gerardo Cardellino; Laura Nicoletti; Lorenzo Fornaro; Andrea Casadei-Gardini; Giuseppe Aprile
Journal:  Gastric Cancer       Date:  2017-05-05       Impact factor: 7.370

Review 8.  Clinical Impact of a Perioperative Exercise Program for Sarcopenia and Overweight/Obesity Gastric Cancer.

Authors:  Toru Aoyama; Masato Nakazono; Shinsuke Nagasawa; Kenki Segami
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

9.  Impact of Visceral Obesity and Sarcopenia on Short-Term Outcomes After Colorectal Cancer Surgery.

Authors:  Wei-Zhe Chen; Xiao-Dong Chen; Liang-Liang Ma; Feng-Min Zhang; Ji Lin; Cheng-Le Zhuang; Zhen Yu; Xiao-Lei Chen; Xiao-Xi Chen
Journal:  Dig Dis Sci       Date:  2018-03-16       Impact factor: 3.199

10.  Sarcopenia predicts 1-year mortality in elderly patients undergoing curative gastrectomy for gastric cancer: a prospective study.

Authors:  Dong-Dong Huang; Xiao-Xi Chen; Xi-Yi Chen; Su-Lin Wang; Xian Shen; Xiao-Lei Chen; Zhen Yu; Cheng-Le Zhuang
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-29       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.